Back to briefingOn watchUnited KingdomFinancial marketsSep 16, 2026, 11:38 AMBarclays cuts Cellectis stock rating on gene editing concernsBarclays cuts Cellectis stock rating on gene editing concernsRead original sourceToday's stories